Steven Yukl UCSF and San Francisco VA

Slides:



Advertisements
Similar presentations
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Advertisements

Measuring the latent HIV Reservoir
“ The therapeutic effect of FIT- 06, GTU®-Multi-HIVB DNA vaccine, observed in HIV-1 infected people. Results of a Phase II trial”. Prof. Mart Ustav SVP,
Hiromi Imamichi, Robin L. Dewar, Da Wei Huang, Dun Liang, Catherine R. Rehm, Ellen Paxinos, Michael Brown, Yan Guo, Colleen Ludka, Colleen Hadigan, Richard.
Unique integration patterns in an in vitro model of HIV-1 latency. Suha M. Saleh, Dimitrios Vatakis, Andrew Harman, Anthony Cunningham, Paul U. Cameron,
Evaluating residual HIV reservoirs Background or why is this important? What can be measured? Where should we measure it? Conclusions.
Gag-positive reservoir cells can be identified by a new technique and can be cleared by CTL ? Una O’Doherty June 29, 2013.
Transcription of viral DNAs. Lecture 14 Flint et al. pp. 253 – 277.
Transcription strategies of viruses
Alternative RNA splicing in latently infected T cells generates chimeric cellular:HIV mRNAs with the potential to generate Tat and reactivate infection.
2014 “Towards an HIV Cure” symposium Melbourne A novel assay that precisely measures the size of the latent HIV reservoir reveals that ART-nai ̈ ve individuals.
2014 “Towards an HIV Cure” symposium Melbourne The Immune Checkpoints PD-1, LAG-3 and TIGIT are Biomarkers of HIV Infected Cells During ART and Identify.
RETROVIRUSES.
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
DNA methylation as an epigenetic marker in HIV-2 disease in West Africa? Alberta Davis MRC Laboratories, Gambia 18th January 2013.
Estrogen blocks HIV re-emergence from latency and points to gender- specific differences in HIV reservoirs Jonathan Karn International AIDS Society Hammer.
Regulation of Gene Expression
I.Regulation of HIV transcription and mechanisims of latency. ii.viral – host interactions. iii.Use of lentiviruses for targeting specific cells for gene.
Eukaryotic Genome & Gene Regulation The entire genome of the eukaryotic organism is present in every cell of the organism. Although all genes are present,
Anti-HIV Antibody Responses Reflect the Quantifiable HIV Reservoir Size Sulggi Lee, M.D., Ph.D. Assistant Professor of Medicine University of California,
Scientific Reading and Writing in English discussion Shu-ying Wang, Ph.D. Dept. Microbiology and Immunology Tel: ext Fax:
Learning About an HIV Cure by Doing Studies in HIV+ Subjects Alan Landay, PhD Professor and Chairman Department of Immunology/Microbiology Rush University.
Myeloid dendritic cells induce HIV-1 latency in non- proliferating CD4 + T cells IAS WORKSHOP, 16 & 17 JULY 2010.
Mathias Lichterfeld, M.D., Ph.D. Massachusetts General Hospital An intrinsic inhibitor of p-TEFb and HIV-1 transcriptional elongation in CD4 T cells from.
HIV: Science, Sex and Society. Lecture 1. Mechanisms of viral persistence in the face of antiviral therapy. Mario Stevenson, Ph.D Department of Medicine.
Mudit Tyagi George Mason University, Manassas, Virginia, USA CBF-1 induces both establishment and maintenance of HIV latency via recruiting PcG corepressor.
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Source: A DULTS AND C HILDREN L IVING WITH HIV/AIDS (Est. Dec 2007) deaths: 2,900,000 in ,100,000 in 2007 new cases: 2,500,000 in.
Gene Regulation, Part 2 Lecture 15 (cont.) Fall 2008.
The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.
Lantiviral Vectors Fazal Tabassam Ph.D Feb.16,2009.
Schematic representation of mechanisms of activation of a host gene by insertion of a provirus and the general structure of leukemia and leukosis and acute.
State of HIV Cure Research
PBMCs from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors show variable susceptibility to HIV-1 infection: searching.
HIV Cure: Current Status and Future Perspectives
Feedback meeting September 2017
Eukaryotic Genome & Gene Regulation
HEATHER Feedback Meeting
The distribution and function of the Adenovirus L4-33K protein
Gene Expression 3B – Gene regulation results in differential gene expression, leading to cell specialization.
Chapter 15 Controls over Genes.
Human Health and Disease
Steps in microRNA gene silencing
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load by Steven G. Deeks, Christina.
Y. Sun, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao, Z. Yu, W. Kang,
The block-and-lock approach
Why we should ‘shock and kill’
Regulation of Gene Expression
Epigenetics Study of the modifications to genes which do not involve changing the underlying DNA
Involvement of SR Proteins in mRNA Surveillance
Review Warm-Up What is the Central Dogma?
Volume 21, Issue 4, Pages e4 (April 2017)
What Integration Sites Tell Us about HIV Persistence
Volume 18, Issue 5, Pages (January 2017)
Volume 29, Issue 1, Pages (January 2008)
Control of the Embryonic Stem Cell State
Volume 25, Issue 3, Pages (February 2007)
Fig. 1 HIV transcription profiles in freshly isolated CD4+ T cells and PBMCs from HIV-infected patients on ART suggest blocks to HIV transcriptional elongation,
Volume 13, Issue 6, Pages (June 2013)
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
An Integrated Overview of HIV-1 Latency
Fig. 2 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART results in successive increases in elongated, polyadenylated, and.
Fig. 3 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART selectively reverses baseline blocks to splicing, elongation, and.
Eukaryotic Gene Regulation
A Role for Epigenetics in Psoriasis: Methylated Cytosine–Guanine Sites Differentiate Lesional from Nonlesional Skin and from Normal Skin  Johann E. Gudjonsson,
Fig. 5 Putative latency-reversing agents exert differential effects on the different blocks to HIV transcription. Putative latency-reversing agents exert.
Fig. 3. The effect of VRC01 infusion on virus load in plasma and blood CD4 T cells during ART. The effect of VRC01 infusion on virus load in plasma and.
Prokaryotes Eukaryotes  
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
Volume 18, Issue 5, Pages (January 2017)
Presentation transcript:

Steven Yukl UCSF and San Francisco VA Residual HIV transcription on ART: implications for latency elimination Steven Yukl UCSF and San Francisco VA

Disclosures I have no financial relationships with commercial entities.

Unclear what mechanisms govern latent HIV infection in vivo Multiple mechanisms have been implicated in HIV latency: Most published studies have relied on in vitro models Most studies have investigated only one mechanism at a time Blocks to initiation of transcription: Integration into transcriptionally-silent regions Epigenetic modification Lack of host cell transcription factors Lack of viral transcription factors (Tat) Transcriptional interference Blocks to elongation of transcription: Lack of host cell elongation factors Lack of Tat Nucleosome positioning Post-transcriptional factors: Lack of Rev Blocks to nuclear export RNA interference

Objectives Simultaneously apply a panel of HIV RNA assays to cells from ART-treated patients in order to: Determine the degree to which different mechanisms inhibit HIV transcription in vivo Measure the degree to which each mechanism is reversed by T cell activation Hypothesis: Latency is primarily due to lack of HIV transcriptional initiation

“Transcription profiling” to investigate the mechanisms that regulate HIV transcription in vivo Read-through Suggests transcriptional interference TAR Found in all HIV transcripts; initiation of transcription LONG LTR Proximal elongation (past 5’ LTR) NEF Distal transcription (3’ end) POLY A Completion of transcription; surrogate for HIV protein TAT-REV Completion of splicing; surrogate for productive infection Bullen et al., 2014 Nat. Med.; Kaiser et al., 2017 J. Virol. Methods; Lenasi et al., 2008 Cell Host Microbe

Methods Blood from HIV+ adults on ART VL<40 c/ml Neg selection using Ab-bound beads Blood from HIV+ adults on ART VL<40 c/ml -80C (day 0, untouched) Extract total RNA and DNA CD4+T cells Activate for 1 and 2 days Aliquots of cells 6-10 x 106 + nevirapine + indinavir +/- antiCD3/28 and IL-2 Trireagent Measure concentration NanoDrop Aliquot RNA 1ug 5ug Poly-A tailing PolyA polymerase Reverse transcription Reverse transcription Poly(dT) + Random hexamers Poly(dT) + Random hexamers Aliquot for ddPCR Aliquot for ddPCR TAR Read-through Long LTR Pol Nef PolyA Tat-Rev Yukl et al, Science Trans Med, 2018

Transcription profile in blood CD4+T indicates blocks to elongation, completion, and splicing Yukl et al, Science Trans Med, 2018 1) Low levels of read-through transcripts; 2) High levels of transcriptional initiation (TAR); 3) Strong blocks to elongation, completion, and multiple splicing

Block to completion represents blocks to distal transcription +/- polyadenylation Yukl et al, Science Trans Med, 2018 A gradient was observed from the 5’LTR to Pol to Nef to the 3’LTR-polyA Suggests blocks to distal elongation and a possible block to polyadenylation

Differences in HIV RNAs can’t be explained by proviral mutations in primer/probe regions Yukl et al, Science Trans Med, 2018 1. Differences between levels of HIV RNAs were preserved even after normalization to the corresponding HIV DNA levels 2. Differences in HIV RNA levels can’t be explained by mutations in HIV DNA at primer/probe regions

Differences in HIV RNA levels can’t be explained by differences in stability

Activation selectively increases elongated, polyadenylated, and spliced transcripts Yukl et al, Science Trans Med, 2018 Median (day2/day0) = 0.75 Median (d2/d0) = 0.87 Median d2/d0 = 1.64 Median d2/d0 = 10.9 Median d2/d0 = 26 The main reversible blocks to HIV transcription are not transcriptional interference or lack of initiation, but blocks to elongation, completion, and splicing

Activation partially reverses blocks to elongation, completion, and splicing Yukl et al, Science Trans Med, 2018 Activation reverses baseline blocks to elongation, completion, and splicing The block to completion is the one most reversed by activation

The cellular distribution of each HIV RNA follows the same pattern as the levels/106 cells Yukl et al, Science Trans Med, 2018 The relative order of cell frequencies positive for each HIV RNA mirrors the levels/106 cells Almost all HIV-infected cells contain TAR transcripts The observed transcriptional blocks operate in most HIV-infected cells

Blocks to elongation, completion, and splicing found in most HIV-infected cells Yukl et al, Science Trans Med, 2018

LRAs exert differential effects on the different blocks Yukl et al, Science Trans Med, 2018 The mechanisms underlying the blocks to completion and splicing may differ from those that mediate the blocks to initiation and elongation

Different mechanisms govern HIV transcription in the rectum >10-fold lower HIV transcriptional initiation (TAR RNA/HIV DNA) in rectal CD4+ T Little or no block to elongation in rectal CD4+ T Blocks to completion and splicing observed in rectal CD4+ T

Blood and gut differ in HIV transcriptional blocks underlying latency

Conclusions The main reversible blocks to HIV expression in circulating CD4+ T cells are not transcriptional interference or lack of initiation, but rather inhibition of elongation, completion, and multiple splicing These blocks to HIV transcription operate in most HIV-infected cells, and are likely the mechanisms of latency in the blood Blocks to HIV transcriptional initiation (as well as completion and splicing) may be important for latency in the gut

Implications The TAR loop may serve as marker and target for HIV-infected cells in the blood Latency reversal may require agents or combinations that reverse all blocks Different therapies may be required to reactivate HIV-infected cells in the tissues There are multiple different steps at which HIV transcription can be silenced Gut cells that are activated but don’t express virus may serve as a model for silencing HIV

Acknowledgments San Francisco VA and UCSF: Philipp Kaiser Peggy Kim Sushama Telwatte Tsui-Hua Chen Sunil Joshi Harry Lampiris Joseph Wong San Francisco VA ID Clinic: Mai Vu UCSF/ZSFGH: Ma Somsouk Chris Baker Sulggi Lee Teri Liegler Mike McCune Jeffrey Milush Peter Hunt Steve Deeks Baylor: Hongbing Liu Andrew Rice University of Zürich Huldrych Günthard Marek Fischer Funding: Dept. of Veterans Affairs NIH amfAR The study participants!

Differences in HIV RNAs are not explained by differences in assay performance Yukl et al, Science Trans Med, 2018

Differences in HIV RNAs can’t be explained by mutations in proviruses Yukl et al, Science Trans Med, 2018 Differences between read-through, TAR, long LTR, Pol, Nef, and polyA RNA were preserved even after normalization to the corresponding HIV DNA

Limitations to Study Methods We are unable to tell how much RNA comes from cells with infectious proviruses. However: It is difficult to demonstrate both inducibility and infectivity without T cell activation, which precludes analysis of the basal transcription patterns. Much regulation of HIV transcription may depend on cellular factors that are independent of viral sequence. Noninfectivity may be a consequence of sequence changes throughout the provirus, but only those that create functional defects in the LTRs or Tat/Rev would affect transcription Cell dilution experiments suggest that the blocks to elongation, completion, and splicing operate in most HIV-infected cells.